Skip to content

Arrowhead Research ARWR Other Working Capital

Other Working Capital at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$7.63M+115%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$306K-1,557%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$0-100%
Amgen logo
AmgenAMGN
$67M+34.0%
ALN
Alnylam PharmaceuticalsALNY
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's other working capital?
Arrowhead Research (ARWR) reported other working capital of -$385K in Q1 2026.
How has Arrowhead Research's other working capital changed year-over-year?
Arrowhead Research's other working capital increased by 78.2% year-over-year, from -$1.77M to -$385K.
What does other working capital mean?
The net change in miscellaneous operating assets and liabilities.
How do you interpret other working capital?
Fluctuations here are often non-recurring; consistent negative values may indicate inefficient management of miscellaneous current assets.
How does other working capital compare across companies?
Varies widely by company depending on what is classified as 'other' in the financial statements.